tiprankstipranks
Advertisement
Advertisement
Anika Shareholders Approve Directors and Expanded Incentive Plans
PremiumCompany AnnouncementsAnika Shareholders Approve Directors and Expanded Incentive Plans
1M ago
Anika Therapeutics Signals Momentum Amid Regulatory Risks
Premium
Company Announcements
Anika Therapeutics Signals Momentum Amid Regulatory Risks
3M ago
Anika Therapeutics Signals Momentum Amid Regulatory Hurdles
Premium
Company Announcements
Anika Therapeutics Signals Momentum Amid Regulatory Hurdles
3M ago
Anika Therapeutics price target raised to $17 from $16 at Barrington
PremiumThe FlyAnika Therapeutics price target raised to $17 from $16 at Barrington
5M ago
Anika Therapeutics price target raised to $18 from $16 at B. Riley
Premium
The Fly
Anika Therapeutics price target raised to $18 from $16 at B. Riley
5M ago
Anika Announces Executive Transition Amid Stable Quarterly Results
Premium
Company Announcements
Anika Announces Executive Transition Amid Stable Quarterly Results
5M ago
Anika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
PremiumThe FlyAnika Therapeutics appoints Griffin as CEO, Blanchard as Executive Chair
7M ago
Anika Therapeutics price target raised to $16 from $15 at Barrington
Premium
The Fly
Anika Therapeutics price target raised to $16 from $15 at Barrington
9M ago
Anika Therapeutics Reports Mixed Q3 2025 Results
Premium
Company Announcements
Anika Therapeutics Reports Mixed Q3 2025 Results
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100